Neuronetics Inc (STIM)

$1.90 +0.09 (4.97%)
Market Cap 123.96M
Revenue (ttm) 74.89M
Net Income (ttm) -43.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -58.37%
Debt to Equity Ratio 2.09
Volume 854,900
Avg Vol 1,721,998
Day's Range N/A - N/A
Shares Out 68.49M
Stochastic %K 69%
Beta 0.66
Analysts Strong Sell
Price Target $6.50

Company Profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific area...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 640 4202
Fax: 610 640 4206
Address:
3222 Phoenixville Pike, Malvern, United States
mankind1
mankind1 Jan. 15 at 5:16 PM
$STIM anyone know why we are seeing this steady of a climb?
1 · Reply
Tree_Llama
Tree_Llama Jan. 10 at 6:23 PM
$STIM very bullish about this one. Although, I think it might take a few months
0 · Reply
CoachHendo
CoachHendo Jan. 9 at 10:05 PM
$STIM 💥 Boom 💥
0 · Reply
JustAnotherGuy007
JustAnotherGuy007 Jan. 9 at 4:57 AM
Short term swings $SYPR expecting 2x by May, low float ~8M shares. Possible defense contract . Low float ~8M shares. $HYFT AI driven bio R&D company , partnered with $AMD, possibly 2x by March/April $STIM develops AI based Neuro-Health products, 2x by May
0 · Reply
DARKP00L
DARKP00L Jan. 8 at 6:03 PM
$STIM momentum building! Stock attracting attention, could be a mover!
0 · Reply
dln101
dln101 Jan. 8 at 5:23 PM
$STIM out for now, will reentr if it it does its usual pullback 🤔
0 · Reply
BullishBee
BullishBee Jan. 8 at 3:18 PM
✅ Back-to-Back: $STIM We just cashed out $STIM for +10.0% again. That is two separate double-digit wins on the same ticker this week. • Entry: $1.76 (Yesterday) • Exit: $1.94 (Today) • Result: Target Hit automatically. We take our losses small so we can capitalize on repeat runners like this. Founder's Rate Access: Limited Spots available. Join the Hive via Link in Bio 🐝
0 · Reply
BullishBee
BullishBee Jan. 7 at 10:22 PM
🧠 AI Strategy: Adding to the Green Column Building on the wins from earlier ($ACRV, $DNN), the AI model locked in three more double-digit runners today. New AI Cash-Outs: ✅ $IMRX: +10.0% (Gap Capture) ✅ $STIM: +10.0% (Overnight Hold) ✅ $IPSC: +9.0% (15-Minute Scalp) The Reality: Trading isn't about being perfect. It's about math. Our winners are paying double our stops, keeping the P&L moving the right way. Founder's Rate Access Closing Soon. 👇 Link in Bio.
0 · Reply
SMD1976
SMD1976 Jan. 7 at 9:23 PM
$STIM I was watching the TV show "Doc" last night and the lead character who had memory issues was undergoing TMS treatments. I don't think this is an indication for the unit made by STIM, but it's probably a positive thing indicating more mainstream acceptance of these treatments.
2 · Reply
BullishBee
BullishBee Jan. 7 at 2:41 PM
The Hive is eating. Are you still watching? 🐝 Another morning, another automatic cash-out. $INTC joined the winner's list today with a clean +7.5%. That's on top of: $COMP (+7.1%) $STIM (+10%) $HOUS (+7.3%) $FFAI (+10%) just this morning. We are stacking wins while the rest of the market chases noise. The door is closing on Founder's Pricing. Do you want to be on the inside getting the alerts, or on the outside reading the recaps? Join the Winning Side. 🐝
0 · Reply
Latest News on STIM
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

Nov 20, 2025, 8:30 AM EST - 2 months ago

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

Nov 18, 2025, 6:40 AM EST - 2 months ago

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

AIRS NOTV

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Nov 12, 2025, 10:33 AM EST - 2 months ago

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 12:26 PM EST - 2 months ago

Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Nov 4, 2025, 7:05 AM EST - 2 months ago

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 31, 2025, 4:30 PM EDT - 2 months ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

Oct 30, 2025, 8:32 AM EDT - 2 months ago

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Oct 21, 2025, 8:30 AM EDT - 3 months ago

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Sep 17, 2025, 8:32 AM EDT - 4 months ago

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:53 PM EDT - 5 months ago

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 4, 2025, 4:30 PM EDT - 5 months ago

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Jul 30, 2025, 8:32 AM EDT - 6 months ago

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Neuronetics Appoints New Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 6 months ago

Neuronetics Appoints New Chief Financial Officer

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Jun 10, 2025, 8:31 AM EDT - 7 months ago

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Jun 2, 2025, 4:30 PM EDT - 8 months ago

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:57 AM EDT - 9 months ago

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

Neuronetics Reports First Quarter 2025 Financial and Operating Results

May 6, 2025, 7:10 AM EDT - 9 months ago

Neuronetics Reports First Quarter 2025 Financial and Operating Results

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Mar 31, 2025, 8:31 AM EDT - 10 months ago

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Mar 29, 2025, 11:45 PM EDT - 10 months ago

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 27, 2025, 4:30 PM EDT - 10 months ago

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 9:52 AM EST - 11 months ago

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 7:10 AM EST - 11 months ago

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Feb 7, 2025, 7:54 AM EST - 1 year ago

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

Feb 6, 2025, 4:23 PM EST - 1 year ago

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Jan 29, 2025, 8:31 AM EST - 1 year ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 10, 2024, 10:00 AM EST - 1 year ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 8:30 AM EST - 1 year ago

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:41 PM EST - 1 year ago

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 6:45 PM EST - 1 year ago

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:10 AM EST - 1 year ago

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

Oct 29, 2024, 4:30 PM EDT - 1 year ago

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Oct 14, 2024, 8:31 AM EDT - 1 year ago

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Oct 4, 2024, 8:33 AM EDT - 1 year ago

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Sep 25, 2024, 8:31 AM EDT - 1 year ago

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

Sep 19, 2024, 8:31 AM EDT - 1 year ago

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

NeuroStar® Releases Software Upgrades to Elevate Patient Care

Sep 16, 2024, 8:32 AM EDT - 1 year ago

NeuroStar® Releases Software Upgrades to Elevate Patient Care

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Sep 3, 2024, 8:29 AM EDT - 1 year ago

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 1:59 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Aug 12, 2024, 1:12 PM EDT - 1 year ago

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Aug 12, 2024, 7:15 AM EDT - 1 year ago

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 7:10 AM EDT - 1 year ago

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Aug 1, 2024, 8:29 AM EDT - 1 year ago

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Jul 30, 2024, 8:30 AM EDT - 1 year ago

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

Jul 22, 2024, 8:31 AM EDT - 1 year ago

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

Jul 11, 2024, 8:36 AM EDT - 1 year ago

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

Jul 10, 2024, 8:32 AM EDT - 1 year ago

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

NeuroStar® Launches Better Me Provider Program Nationwide

Jul 1, 2024, 8:02 AM EDT - 1 year ago

NeuroStar® Launches Better Me Provider Program Nationwide

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

Jun 13, 2024, 8:31 AM EDT - 1 year ago

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

May 23, 2024, 8:30 AM EDT - 1 year ago

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

mankind1
mankind1 Jan. 15 at 5:16 PM
$STIM anyone know why we are seeing this steady of a climb?
1 · Reply
Tree_Llama
Tree_Llama Jan. 10 at 6:23 PM
$STIM very bullish about this one. Although, I think it might take a few months
0 · Reply
CoachHendo
CoachHendo Jan. 9 at 10:05 PM
$STIM 💥 Boom 💥
0 · Reply
JustAnotherGuy007
JustAnotherGuy007 Jan. 9 at 4:57 AM
Short term swings $SYPR expecting 2x by May, low float ~8M shares. Possible defense contract . Low float ~8M shares. $HYFT AI driven bio R&D company , partnered with $AMD, possibly 2x by March/April $STIM develops AI based Neuro-Health products, 2x by May
0 · Reply
DARKP00L
DARKP00L Jan. 8 at 6:03 PM
$STIM momentum building! Stock attracting attention, could be a mover!
0 · Reply
dln101
dln101 Jan. 8 at 5:23 PM
$STIM out for now, will reentr if it it does its usual pullback 🤔
0 · Reply
BullishBee
BullishBee Jan. 8 at 3:18 PM
✅ Back-to-Back: $STIM We just cashed out $STIM for +10.0% again. That is two separate double-digit wins on the same ticker this week. • Entry: $1.76 (Yesterday) • Exit: $1.94 (Today) • Result: Target Hit automatically. We take our losses small so we can capitalize on repeat runners like this. Founder's Rate Access: Limited Spots available. Join the Hive via Link in Bio 🐝
0 · Reply
BullishBee
BullishBee Jan. 7 at 10:22 PM
🧠 AI Strategy: Adding to the Green Column Building on the wins from earlier ($ACRV, $DNN), the AI model locked in three more double-digit runners today. New AI Cash-Outs: ✅ $IMRX: +10.0% (Gap Capture) ✅ $STIM: +10.0% (Overnight Hold) ✅ $IPSC: +9.0% (15-Minute Scalp) The Reality: Trading isn't about being perfect. It's about math. Our winners are paying double our stops, keeping the P&L moving the right way. Founder's Rate Access Closing Soon. 👇 Link in Bio.
0 · Reply
SMD1976
SMD1976 Jan. 7 at 9:23 PM
$STIM I was watching the TV show "Doc" last night and the lead character who had memory issues was undergoing TMS treatments. I don't think this is an indication for the unit made by STIM, but it's probably a positive thing indicating more mainstream acceptance of these treatments.
2 · Reply
BullishBee
BullishBee Jan. 7 at 2:41 PM
The Hive is eating. Are you still watching? 🐝 Another morning, another automatic cash-out. $INTC joined the winner's list today with a clean +7.5%. That's on top of: $COMP (+7.1%) $STIM (+10%) $HOUS (+7.3%) $FFAI (+10%) just this morning. We are stacking wins while the rest of the market chases noise. The door is closing on Founder's Pricing. Do you want to be on the inside getting the alerts, or on the outside reading the recaps? Join the Winning Side. 🐝
0 · Reply
BullishBee
BullishBee Jan. 7 at 1:27 PM
Morning Update: $STIM The AI model positioned us yesterday morning at $1.60. We held overnight and the target was hit automatically at 4AM today. Trade Details: • Entry: $1.60 • Exit: $1.76 • Result: +10.0% (Secured) The best way to start the trading day is with a closed winner. 💎 Founder's Rates Closing Soon. Link in Bio.
0 · Reply
Gushihoudewo
Gushihoudewo Jan. 7 at 10:23 AM
0 · Reply
Gushihoudewo
Gushihoudewo Jan. 7 at 10:22 AM
$STIM So few people here, but this one is excellent, wish this a target price about 15 dollars (Musk Neuralink will push STIM to a high level)!
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 6 at 10:29 PM
🎯 Target Hit 🏁 📨 From Jan 2, 2026 💊 $STIM 💵 Entry: $1.4100 ✅ Ext: $1.6800 💰 P/L: +19.15% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
DarkSonar
DarkSonar Jan. 6 at 4:19 PM
$STIM Shit stocks market galore this January!!! All these pennies are looking great for moves. I began compiling and scanning for shit stocks with high probability potential and I am monitoring. Doing DD. 🔬
0 · Reply
bblackm5
bblackm5 Jan. 6 at 4:06 PM
$STIM $2 gap?
0 · Reply
CoachHendo
CoachHendo Jan. 2 at 8:15 PM
$STIM DT!
0 · Reply
FORMER
FORMER Dec. 26 at 9:12 AM
$STIM On 3/6 Institutional Shares were 8,715,425 - 15.66% and today (12/26) Institutional Shares are now 23,066,980 - 33.68% 🤙
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 5:39 PM
$STIM Share Price: $1.42 Contract Selected: Aug 21, 2026 $1.0 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.77 – $0.94 Potential Upside: 71% ROI Time to Expiration: 239 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
InheritedWealth
InheritedWealth Dec. 24 at 10:15 AM
$STIM The longer-term setup revolves around whether management navigates capital constraints while advancing core initiatives. Clear inflection points are required to justify renewed interest.
0 · Reply
MadMaverick
MadMaverick Dec. 24 at 12:49 AM
$SPY $NKE $STIM $TSLA $PATH
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 23 at 3:57 AM
$STIM RSI: 58.73, MACD: -0.1280 Vol: 0.13, MA20: 1.43, MA50: 2.06 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply